Literature DB >> 30672662

Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma.

Michael R Sargen1, Jeffrey M Cloutier1, Kavita Y Sarin2, Kerri E Rieger1,2, Pauline Chu1, Susan M Swetter2,3, Roberto A Novoa1,2.   

Abstract

Entities:  

Keywords:  BAP1; biomarker; melanoma; p14ARF; p16; p53; prognosis

Mesh：

Substances：

Year:  2019        PMID： 30672662     DOI： 10.1111/pcmr.12768

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  1 in total

Review 1.  Selected Flavonoids to Target Melanoma: A Perspective in Nanoengineering Delivery Systems.

Authors:  Tiago E Coutinho; Eliana B Souto; Amélia M Silva
Journal:  Bioengineering (Basel)       Date:  2022-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.